INVESTORS

investors

News Release

<< Back
Printer Friendly Version View printer-friendly version
New U.S. Grant From HHS Studies Impact of Zix Corporation's e-Prescribing Solution in Mass.

PocketScript(R) named in Mass. General Hospital study: "E-Prescribing Impact on Patient Safety, Use and Cost"

DALLAS, Oct 15, 2004 (BUSINESS WIRE) -- Zix Corporation (ZixCorp(R)), (Nasdaq:ZIXI), a global provider of e-messaging, e-prescribing, and e-transaction applications and services, today announced it was notified on Wednesday that PocketScript, its e-prescribing application, will be studied by a Health & Human Services (HHS) grant recipient, Massachusetts General Hospital in Boston. This grant, an estimated $1.122 million over three years, will be used to assess the impact of a statewide rollout of e-prescribing using PocketScript and to determine its effect on safety, quality, cost, formulary compliance, and outcomes.

The HHS grants and contracts, totaling $139 million, will promote the use of health information technologies (HIT) and provide insight into how to best use it to improve the efficiency of healthcare. e-Prescribing helps improve patient safety by reducing medication errors; increasing the use of shared health information between providers, laboratories, pharmacies, and patients. The technology also helps to ensure safer patient transitions in healthcare settings, including hospitals, doctors' offices, and nursing homes; and reduces duplicative and unnecessary testing.

PocketScript creates both new and refilled electronic prescriptions, identifies drug-to-drug and drug-to-allergy interactions, and enables clinicians to review a patient's drug history while providing an electronic link to some health plans for real-time formulary coverage information. It also facilitates transmission of prescriptions to both retail and mail-order pharmacies.

The press release issued by the U.S. Department of Health & Human Services can be found at http://www.hhs.gov/news/press/2004pres/20041013.html.

About Zix Corporation

Zix Corporation (ZixCorp(R)) is a global provider of secure e-messaging, e-prescribing, and e-transaction applications and services. ZixCorp offers a range of solutions to protect organizations from viruses, spam, and electronic attack, as well as enabling secure electronic communications, such as email encryption, e-prescribing, on-line doctor visits, and electronic lab orders and results. ZixCorp helps organizations of any size to streamline operations, reduce risks, and leverage the efficiencies of e-messaging. For more information, visit www.zixcorp.com.

SOURCE: Zix Corporation

Zix Corporation, Dallas
Public Relations:
Christa Osswald, 214-370-2175
publicrelations@zixcorp.com
or
Investor Relations:
Peter Wilensky, 214-515-7357
invest@zixcorp.com